LSX Investable Showcase 2019 Square White-1

   CONNECTING LIFE SCIENCE & HEALTHCARE COMPANIES WITH CAPITAL



19 November 2019 | Waldorf Hilton Hotel | London

 

#Investival

DOWNLOAD BROCHURE

 

 
In partnership with

Jefferies Investment Bank


Connecting life science corporates with capital as part of Europe's biggest healthcare-dedicated investment week

Defn: investival showcase

/ˈin:fɛstɪv(ə)l ˈʃəʊkeɪs/ 

noun: 

  1. 1. An organised day of presentations and 1-2-1 partnering meetings held annually for life
  2. science executives, investors and pharma, typically for finance raising and partnering reasons.




4th Annual Inv€$tival Showcase

What is it and who is it for? 

Returning for its fourth year, LSX’s Investival Showcase continues and expands upon its exclusive partnership with global investment bank Jefferies, with the showcase co-located with the Jefferies 2019 London Healthcare Conference.

The Investival Showcase directly connects life sciences corporates to global capital.

A multi-streamed showcase of early, growth stage and public life science and health technology companies, Investival Showcase offers the opportunity for a greater proportion of private and smaller cap public companies to be a part of the biggest week in European life sciences investment. It provides the opportunity to pitch, profile and connect with investment partners brought together in London by both LSX, and Jefferies.

Over the last three years, Investival Showcase has welcomed numerous companies across all areas of biotech, medtech and healthtech who have been looking to raise their capital and profile amongst investors. We'd like to talk to all companies about the options available for joining the event and the showcase but our investor network are always particularly interested in innovations in oncology, neurology, infectious diseases, immunology, cardiovascular, musculoskeletal, respiratory, cardiometabolic, as well as medtech and healthtech in all areas. 


Investival Audience

Confirmed Keynote Speakers

Graziano Seghezzi

Graziano Seghezzi
Managing Partner, Sofinnova

Vanessa Mailer 300x

Vanessa Malier
Managing Partner, Kurma Partners

Roel Bulthuis

Roel Bulthuis
Managing Partner, Inkef Capital

Laia Crespo

Laia Crespo
Head of Europe, Sanofi Ventures

Giovanni Mariggi, Partner, Medicxi

Giovanni Mariggi
Partner, Medicxi

regina hodits wellington

Regina Hodits
Managing Partner, Wellington Partners

gil bar nahum

Gil Bar-Nahum
Managing Director,
Jefferies 

2018 Key

Showcase Stats



300+

EXECUTIVES



800+

ONSITE 1-2-1 MEETINGS



5%

PHARMA & COMMERCIAL LEADERS



60+

SHOWCASES



36%

INVESTORS



12%

FINANCIAL & PROFESSIONAL
SERVICES


125+

INVESTORS


37%

LIFE SCIENCE COMPANIES

 
2019 Current investors include 

Apollo Ventures 300x-1
AV8 Ventures-1
Cascara Ventures-3-1
DDF Ventures 300x
HMC 300x

Kreos Capital 300x

Optum Ventures 300x

Pontifax 300x

ALL INVESTORS

Seventure-1


Science to Business 300x


Contact Us

For Speaker enquiries contact:

Josh Dance, SVP
Josh@lsxleaders.com

For Sponsor enquiries contact: 

Matt Pullan, SVP Business Development
Matt@lsxleaders.com

For Media enquiries contact: 

Russell Gardiner, Marketing Manager
Russell@lsxleaders.com